RE: RNS4 Dec 2024 21:21
I bet Martin D is about as happy as the rest of us. Such a low point to raise at. My view for what it's worth, they want to take this all the way, maybe with a partner. Timelines will likely slip more, especially with the additional cohorts, probably coming back for more funds late 2025 early 2026. Redmile convertible loan notes pushed out to 2027 should have told us this really.
On the 2 x Genmab deals I actually thought that would underline a 60p share price, should an offer come in for the mabs side of the business. How nieve am I!!
I think now there will be plenty of time to get out, try and recover losses and get back in at these levels later next year as every good rns gets heavily sold into. Just my opinion.